-
Je něco špatně v tomto záznamu ?
Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction
YNV. Reddy, TP. Olson, M. Obokata, V. Melenovsky, BA. Borlaug,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural
Grantová podpora
R01 HL128526
NHLBI NIH HHS - United States
T32 HL007111
NHLBI NIH HHS - United States
U01 HL125205
NHLBI NIH HHS - United States
U10 HL110262
NHLBI NIH HHS - United States
R01 HL126638
NHLBI NIH HHS - United States
- MeSH
- dospělí MeSH
- dyspnoe etiologie MeSH
- hemodynamika MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- spotřeba kyslíku * MeSH
- srdeční katetrizace MeSH
- srdeční selhání komplikace diagnóza patofyziologie MeSH
- studie případů a kontrol MeSH
- supinační poloha MeSH
- tepový objem * MeSH
- tlak MeSH
- tolerance zátěže MeSH
- zátěžový test metody MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Research Support, N.I.H., Extramural MeSH
OBJECTIVES: This study sought to define the invasive hemodynamic correlates of peak oxygen consumption (Vo2) in both supine and upright exercise in heart failure with preserved ejection fraction (HFpEF) and evaluate its diagnostic role as a method to discriminate HFpEF from noncardiac etiologies of dyspnea (NCD). BACKGROUND: Peak Vo2 is depressed in patients with HFpEF. The hemodynamic correlates of reduced peak Vo2 and its role in the clinical evaluation of HFpEF are unclear. METHODS: Consecutive patients with dyspnea and normal EF (N = 206) undergoing both noninvasive upright and invasive supine cardiopulmonary exercise testing were examined. Patients with invasively verified HFpEF were compared with those with NCD. RESULTS: Compared with NCD (n = 72), HFpEF patients (n = 134) displayed lower peak Vo2 during upright and supine exercise. Left heart filling pressures during exercise were inversely correlated with peak Vo2 in HFpEF, even after accounting for known determinants of O2 transport according to the Fick principle. Very low upright peak Vo2 (<14 ml/kg/min) discriminated HFpEF from NCD with excellent specificity (91%) but poor sensitivity (50%). Preserved peak Vo2 (>20 ml/kg/min) excluded HFpEF with high sensitivity (90%) but had poor specificity (49%). Intermediate peak Vo2 cutoff points were associated with substantial overlap between cases and NCD. CONCLUSIONS: Elevated cardiac filling pressure during exercise is independently correlated with reduced exercise capacity in HFpEF, irrespective of body position, emphasizing its importance as a novel therapeutic target. Noninvasive cardiopulmonary testing discriminates HFpEF and NCD at high and low values, but additional testing is required for patients with intermediate peak Vo2.
Department of Cardiovascular Medicine Mayo Clinic Rochester Minnesota
Institute for Clinical and Experimental Medicine Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045441
- 003
- CZ-PrNML
- 005
- 20200114152820.0
- 007
- ta
- 008
- 200109s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jchf.2018.03.003 $2 doi
- 035 __
- $a (PubMed)29803552
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Reddy, Yogesh N V $u Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
- 245 10
- $a Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction / $c YNV. Reddy, TP. Olson, M. Obokata, V. Melenovsky, BA. Borlaug,
- 520 9_
- $a OBJECTIVES: This study sought to define the invasive hemodynamic correlates of peak oxygen consumption (Vo2) in both supine and upright exercise in heart failure with preserved ejection fraction (HFpEF) and evaluate its diagnostic role as a method to discriminate HFpEF from noncardiac etiologies of dyspnea (NCD). BACKGROUND: Peak Vo2 is depressed in patients with HFpEF. The hemodynamic correlates of reduced peak Vo2 and its role in the clinical evaluation of HFpEF are unclear. METHODS: Consecutive patients with dyspnea and normal EF (N = 206) undergoing both noninvasive upright and invasive supine cardiopulmonary exercise testing were examined. Patients with invasively verified HFpEF were compared with those with NCD. RESULTS: Compared with NCD (n = 72), HFpEF patients (n = 134) displayed lower peak Vo2 during upright and supine exercise. Left heart filling pressures during exercise were inversely correlated with peak Vo2 in HFpEF, even after accounting for known determinants of O2 transport according to the Fick principle. Very low upright peak Vo2 (<14 ml/kg/min) discriminated HFpEF from NCD with excellent specificity (91%) but poor sensitivity (50%). Preserved peak Vo2 (>20 ml/kg/min) excluded HFpEF with high sensitivity (90%) but had poor specificity (49%). Intermediate peak Vo2 cutoff points were associated with substantial overlap between cases and NCD. CONCLUSIONS: Elevated cardiac filling pressure during exercise is independently correlated with reduced exercise capacity in HFpEF, irrespective of body position, emphasizing its importance as a novel therapeutic target. Noninvasive cardiopulmonary testing discriminates HFpEF and NCD at high and low values, but additional testing is required for patients with intermediate peak Vo2.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a srdeční katetrizace $7 D006328
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a dyspnoe $x etiologie $7 D004417
- 650 _2
- $a zátěžový test $x metody $7 D005080
- 650 _2
- $a tolerance zátěže $7 D017079
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční selhání $x komplikace $x diagnóza $x patofyziologie $7 D006333
- 650 _2
- $a hemodynamika $7 D006439
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a spotřeba kyslíku $7 D010101
- 650 _2
- $a tlak $7 D011312
- 650 12
- $a tepový objem $7 D013318
- 650 _2
- $a supinační poloha $7 D016683
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 700 1_
- $a Olson, Thomas P $u Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
- 700 1_
- $a Obokata, Masaru $u Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
- 700 1_
- $a Melenovsky, Vojtech $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Borlaug, Barry A $u Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: borlaug.barry@mayo.edu.
- 773 0_
- $w MED00184931 $t JACC. Heart failure $x 2213-1787 $g Roč. 6, č. 8 (2018), s. 665-675
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29803552 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200114153152 $b ABA008
- 999 __
- $a ok $b bmc $g 1483710 $s 1084114
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 6 $c 8 $d 665-675 $e 20180523 $i 2213-1787 $m JACC. Heart failure $n JACC Heart Fail $x MED00184931
- GRA __
- $a R01 HL128526 $p NHLBI NIH HHS $2 United States
- GRA __
- $a T32 HL007111 $p NHLBI NIH HHS $2 United States
- GRA __
- $a U01 HL125205 $p NHLBI NIH HHS $2 United States
- GRA __
- $a U10 HL110262 $p NHLBI NIH HHS $2 United States
- GRA __
- $a R01 HL126638 $p NHLBI NIH HHS $2 United States
- LZP __
- $a Pubmed-20200109